Andrew I. Koven

Overview

Andrew I. Koven received an average of $6.3M in compensation at Aralez Pharmaceuticals from 2015 to 2017.

Source: SEC filings on May 18, 2018 and March 23, 2017.

Related executives

We found five more executives who work or worked at Aralez Pharmaceuticals.

Adrian Adams

Aralez Pharmaceuticals

Chief Executive Officer

Scott Charles

Aralez Pharmaceuticals

Chief Financial Officer

James Tursi

Aralez Pharmaceuticals

Chief Medical Officer

Mark Glickman

Aralez Pharmaceuticals

Former Chief Commercial Officer

Michael Kaseta

Aralez Pharmaceuticals

Chief Financial Officer

You may also like